Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NSCLC × Docetaxel × Clear all

Phase

Phase 3 2 Phase NA 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 2 Head and Neck Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Neoplasms, Second Primary 1 NSCLC 1 Locally Advanced Breast Cancer 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

icotinib 2 anlotinib 2 Thalidomide 1 Drug Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03799601 2019-01-10

ALTER-L013

Tongji Hospital

Phase 4 Unknown

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡